PLx Pharma Inc. Appoints Efthymios Deliargyris as Chief Medical Officer
August 31, 2018 at 04:15 pm
On August 29, 2018, PLx Pharma Inc. entered into an employment agreement with Efthymios Deliargyris in connection with his appointment as the Company's Chief Medical Officer, transitioning from his role as the Company's Chief Medical Advisor. The Executive's employment hereunder shall be effective as of as of August 29, 2018. The Executive shall serve as Chief Medical Officer, reporting directly to the Chief Executive Officer of the Company and the Board of Directors of the Company.